Genome Sequence-Based Screening for Childhood Risk and Newborn Illness

描述（由申请人提供）：这个高度协作的多学科项目将测试新生儿时期基因组测序的可行性及其对医生和家长的影响，以评估儿童发病的未来风险，并指导患病新生儿的诊断和治疗。将建立向新生儿和儿科医生报告基因组测序结果的管道和流程，并开展试点临床试验，探索在新生儿期提供基因组测序结果的影响。为了评估基因组筛查在健康新生儿中的应用，240名新生儿及其父母将在布里格姆妇女医院（Brigham and Women's Hospital）出生后不久登记。为了评估早期基因组筛查作为临床医生照顾患病婴儿的一种资源的使用，来自波士顿儿童医院新生儿重症监护室的240名新生儿将与他们的父母一起登记。该试验将随机选取480名新生儿，分别接受1)从基因组测序和当前新生儿筛查中获得的临床有意义的信息，或2)仅将当前新生儿筛查作为标准护理。项目1将在clia批准的管道中快速测序，分析和解释基因组测序，并向两组新生儿的家庭和儿科护理团队提供易于理解和有用的报告。项目2将招募新生儿及其父母加入该协议，为家庭和儿科医生提供一个遗传学专家团队作为资源，并在临床实践中安全地监测基因组信息的使用。项目3将检查注册父母的偏好和动机，评估临床互动中基因组信息的流动和利用，并评估在新生儿中使用基因组测序相关的理解、行为、医疗后果和医疗成本。

DESCRIPTION (provided by applicant): This highly collaborative multi-disciplinary initiative will test the feasibility and impact on physicians and parents of genomic sequencing in the newborn period to assess future risk of childhood onset disease, as well as to guide diagnosis and treatment of sick newborns. A pipeline and process will be developed for reporting results of genomic sequencing to neonatologists and pediatricians, and a pilot clinical trial will be conducted to explore the impact of delivering genomic sequencing results in the newborn period. To evaluate the use of genomic screening in healthy newborns, 240 newborn infants and their parents will be enrolled shortly after birth at Brigham and Women's Hospital. To evaluate the use of early genomic screening as a resource for clinicians caring for infants who are ill, 240 newborns from the NICU at Boston Children's Hospital will be enrolled along with their parents. The trial will randomize these 480 newborns to receive either 1) clinically meaningful information derived from genomic sequencing and current newborn screening or 2) only current newborn screening as standard of care. Project 1 will rapidly sequence, analyze arid interpret genomic sequencing in a CLIA-approved pipeline and deliver an understandable and useful report to the family and pediatric care team of newborns in both groups. Project 2 will enroll newborns and their parents into the protocol, provide a team of genetics experts as a resource for families and pediatricians, and safely monitor the use of genomic information in clinical practice. Project 3 will examine preferences and motivations of enrolled parents, evaluate the flow and utilization of genomic information within clinical interactions and assess understanding, behavior, medical consequences and healthcare costs associated with the use of genomic sequencing in newborns.